Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics.

Michael Gerckens, Kenji Schorpp, Francesco Pelizza, Melanie Wögrath, Kora Reichau, Huilong Ma, Armando-Marco Dworsky, Arunima Sengupta, Mircea Gabriel Stoleriu, Katharina Heinzelmann, Juliane Merl-Pham, Martin Irmler, Hani N Alsafadi, Eduard Trenkenschuh, Lenka Sarnova, Marketa Jirouskova, Wolfgang Frieß, Stefanie M Hauck, Johannes Beckers, Nikolaus KneidingerJürgen Behr, Anne Hilgendorff, Kamyar Hadian, Michael Lindner (Co-author), Melanie Königshoff, Oliver Eickelberg, Martin Gregor, Oliver Plettenburg, Ali Önder Yildirim, Gerald Burgstaller

Research output: Contribution to journalOriginal Articlepeer-review

12 Citations (Web of Science)
Original languageEnglish
Pages (from-to)eabb3673
JournalSCIENCE ADVANCES
Volume7
Issue number52
DOIs
Publication statusPublished - 2021

Keywords

  • IDIOPATHIC PULMONARY-FIBROSIS
  • GROWTH-FACTOR-BETA
  • SELECTIVE-INHIBITION
  • ACUTE EXACERBATION
  • LABEL-FREE
  • PROTEOME
  • MATRIX
  • TRIAL
  • MECHANISMS
  • TRANILAST

Cite this